Tacrine, the first acetylcholinesterase inhibitor approved clinically for the treatment of AD, was shown to significantly suppress SWDs in aged Wistar rats at a dose of 3 mg/kg40, which also was most effective dose in improving spatial memory in aged rats41. The gene discussed is ACHE; the disease is Alzheimer disease.